Is Strides Pharma technically bullish or bearish?

Overview of Current Technical Trend

As of 27 Nov 2025, Strides Pharma’s overall technical trend has moderated from a clear bullish stance to a mildly bullish one. This subtle shift reflects a market environment where upward momentum persists but is tempered by emerging bearish signals. The stock’s current price stands at ₹892.00, slightly below the previous close of ₹903.80, indicating some short-term pressure.

The 52-week price range remains wide, with a high of ₹1,024.90 and a low of ₹530.70, underscoring significant volatility over the past year. Today’s trading range between ₹885.00 and ₹912.75 further illustrates this variability.

Key Technical Indicators: Mixed Signals

Examining the technical indicators in detail reveals a blend of bullish and bearish elements. The Moving Average Convergence Divergence (MACD) remains bullish on both weekly and monthly charts, signalling sustained positive momentum in the medium to long term. Similarly, daily moving averages support a bullish outlook, suggesting that the stock price is trading above key average levels, which often acts as a support.

Bollinger Bands on weekly and monthly timeframes are mildly bullish, indicating that the stock is trading near the upper band but without extreme volatility. This suggests a controlled upward trend rather than an overextended rally.

However, the Relative Strength Index (RSI) on both weekly and monthly charts shows no clear signal, implying that the stock is neither overbought nor oversold. This neutral stance means momentum is not decisively favouring buyers or sellers at present.

Bearish Indicators Temper Optimism

Contrasting the bullish signals, the Know Sure Thing (KST) indicator is mildly bearish on weekly and monthly charts. This momentum oscillator’s negative reading suggests some weakening in price strength, which could foreshadow a short-term correction or consolidation phase.

Dow Theory analysis presents a split view: mildly bearish on the weekly timeframe but bullish on the monthly. This divergence indicates that while short-term trends may face resistance, the longer-term outlook remains constructive.

On balance, the On-Balance Volume (OBV) indicator is mildly bearish weekly but bullish monthly, reflecting mixed investor sentiment. The weekly bearishness in OBV could point to recent selling pressure, whereas the monthly bullishness suggests accumulation over a longer horizon.

Performance Comparison with Sensex

Strides Pharma’s price performance relative to the benchmark Sensex index offers additional context. Over the past week, the stock declined by 3.44%, underperforming the Sensex’s modest 0.10% gain. This short-term weakness aligns with some of the bearish technical signals observed.

However, over longer periods, Strides Pharma has significantly outperformed the Sensex. The one-month return of 9.65% dwarfs the Sensex’s 1.11%, while year-to-date gains of 35.64% far exceed the benchmark’s 9.70%. Even over one, three, and five-year horizons, Strides Pharma’s returns have been substantially higher, reflecting strong fundamental and market positioning within the Pharmaceuticals & Biotechnology sector.

Technical Outlook: Cautious Optimism

The current technical landscape suggests cautious optimism for Strides Pharma. The predominance of bullish indicators such as MACD and moving averages, combined with strong medium to long-term price performance, supports a positive outlook. Yet, the presence of mildly bearish signals from KST, Dow Theory (weekly), and OBV (weekly) advises prudence.

Investors should be mindful of potential short-term volatility or consolidation phases, especially given the recent price dip and mixed momentum readings. The stock’s proximity to its 52-week high also raises the possibility of resistance levels impacting near-term gains.

Investor Considerations and Strategy

For investors evaluating Strides Pharma, the technical data suggests a strategy that balances opportunity with risk management. Those with a medium to long-term horizon may find the stock’s bullish monthly indicators and historical outperformance compelling reasons to hold or accumulate.

Conversely, short-term traders should monitor weekly bearish signals and price action closely, as these may indicate periods of correction or sideways movement. Employing stop-loss orders and watching volume trends could help mitigate downside risk.

Additionally, given the stock’s sector affiliation with Pharmaceuticals & Biotechnology, investors should remain attentive to broader industry developments, regulatory changes, and company-specific news that could influence technical trends.

Conclusion: Mildly Bullish with Mixed Signals

In summary, Strides Pharma currently exhibits a mildly bullish technical profile. The stock benefits from strong momentum indicators on monthly and daily charts, supported by solid historical returns relative to the Sensex. However, the presence of some weekly bearish signals and recent price softness warrants a measured approach.

Investors are advised to consider both the positive long-term technical cues and the short-term cautionary signs when making investment decisions. A balanced view that recognises the stock’s potential upside alongside possible near-term volatility will best serve those looking to capitalise on Strides Pharma’s market position.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →